In a phase 3 trial, combining cytoreductive surgery with chemotherapy significantly prolonged progression-free and overall survival among select patients with recurrent ovarian cancer.
Medscape Medical News …read more
In a phase 3 trial, combining cytoreductive surgery with chemotherapy significantly prolonged progression-free and overall survival among select patients with recurrent ovarian cancer.
Medscape Medical News …read more